Operating Income (Loss) in USD of ATOSSA THERAPEUTICS, INC. from Q3 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
ATOSSA THERAPEUTICS, INC. quarterly/annual Operating Income (Loss) history and change rate from Q3 2011 to Q3 2025.
  • ATOSSA THERAPEUTICS, INC. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$9.25M, a 44.9% decline year-over-year.
  • ATOSSA THERAPEUTICS, INC. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$32.9M, a 11.4% decline year-over-year.
  • ATOSSA THERAPEUTICS, INC. annual Operating Income (Loss) for 2024 was -$27.6M, a 12% increase from 2023.
  • ATOSSA THERAPEUTICS, INC. annual Operating Income (Loss) for 2023 was -$31.4M, a 13.3% decline from 2022.
  • ATOSSA THERAPEUTICS, INC. annual Operating Income (Loss) for 2022 was -$27.7M, a 34.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

ATOSSA THERAPEUTICS, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$32.9M -$9.25M -$2.87M -44.9% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 -$30M -$9.04M -$1.94M -27.2% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 -$28.1M -$7.41M -$434K -6.22% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025
Q4 2024 -$27.6M -$7.15M +$1.87M +20.7% 01 Oct 2024 31 Dec 2024 10-K 25 Mar 2025
Q3 2024 -$29.5M -$6.39M +$1.08M +14.5% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$30.6M -$7.11M +$688K +8.83% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$31.3M -$6.98M +$118K +1.66% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025
Q4 2023 -$31.4M -$9.02M -$874K -10.7% 01 Oct 2023 31 Dec 2023 10-K 25 Mar 2025
Q3 2023 -$30.5M -$7.47M +$737K +8.98% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$31.2M -$7.79M -$1.2M -18.2% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 -$30M -$7.1M -$2.35M -49.5% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 -$27.7M -$8.14M -$3.32M -68.7% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 -$24.4M -$8.21M -$3.05M -59.1% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$21.3M -$6.6M +$409K +5.84% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$21.7M -$4.75M -$1.22M -34.4% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$20.5M -$4.83M -$603K -14.3% 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 -$19.9M -$5.16M -$1.65M -47% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 -$18.3M -$7M -$3.07M -78% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 -$15.2M -$3.53M -$594K -20.2% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 -$14.6M -$4.23M -$1.61M -61.5% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 -$13M -$3.51M -$211K -6.39% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$12.8M -$3.94M +$3.35M +46% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 -$16.1M -$2.94M +$1.13M +27.7% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q4 2019 -$17.3M -$2.62M -$510K -24.2% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 -$16.8M -$3.3M +$11.8K +0.36% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 -$16.8M -$7.29M -$3.14M -75.9% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 -$13.6M -$4.06M -$2.19M -117% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 -$11.4M -$2.11M -$114K -5.71% 01 Oct 2018 31 Dec 2018 10-K 26 Mar 2020
Q3 2018 -$11.3M -$3.31M -$1.25M -61% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 -$10.1M -$4.14M -$2.25M -118% 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019
Q1 2018 -$7.82M -$1.87M -$171K -10% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019
Q4 2017 -$7.65M -$1.99M +$367K +15.5% 01 Oct 2017 31 Dec 2017 10-K 28 Mar 2019
Q3 2017 -$8.02M -$2.06M -$497K -31.9% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$7.52M -$1.9M -$174K -10.1% 01 Apr 2017 30 Jun 2017 10-Q/A 13 Nov 2018
Q1 2017 -$7.34M -$1.7M +$624K +26.8% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q4 2016 -$7.97M -$2.36M +$113K +4.55% 01 Oct 2016 31 Dec 2016 10-K 08 Mar 2018
Q3 2016 -$8.08M -$1.56M +$2.28M +59.4% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017
Q2 2016 -$10.4M -$1.72M +$1.45M +45.7% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$11.8M -$2.33M +$945K +28.9% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017
Q4 2015 -$12.8M -$2.47M +$856K +25.7% 01 Oct 2015 31 Dec 2015 10-K/A 21 Mar 2017
Q3 2015 -$13.6M -$3.84M -$597K -18.4% 01 Jul 2015 30 Sep 2015 10-Q/A 21 Mar 2017
Q2 2015 -$13M -$3.17M +$16K +0.5% 01 Apr 2015 30 Jun 2015 10-Q/A 21 Mar 2017
Q1 2015 -$13M -$3.27M -$862K -35.7% 01 Jan 2015 31 Mar 2015 10-Q/A 21 Mar 2017
Q4 2014 -$12.2M -$3.33M -$570K -20.7% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 -$11.6M -$3.25M +$257K +7.33% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015
Q2 2014 -$11.9M -$3.19M -$603K -23.3% 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015
Q1 2014 -$11.3M -$2.41M -$469K -24.2% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015
Q4 2013 -$10.8M -$2.76M -$1.05M -61.7% 01 Oct 2013 31 Dec 2013 10-K 30 Mar 2015
Q3 2013 -$9.73M -$3.5M -$2.37M -208% 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014
Q2 2013 -$7.37M -$2.58M -$1.42M -122% 01 Apr 2013 30 Jun 2013 10-Q 12 Aug 2014
Q1 2013 -$5.95M -$1.94M -$879K -82.8% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014
Q4 2012 -$5.07M -$1.71M 01 Oct 2012 31 Dec 2012 10-K 27 Mar 2014
Q3 2012 -$1.14M +$139K +10.9% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013
Q2 2012 -$1.17M 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 -$1.06M 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q3 2011 -$1.27M 01 Jul 2011 30 Sep 2011 10-Q/A 22 Jan 2013

ATOSSA THERAPEUTICS, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$27.6M +$3.76M +12% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025
2023 -$31.4M -$3.69M -13.3% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025
2022 -$27.7M -$7.17M -34.9% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 -$20.5M -$5.91M -40.5% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023
2020 -$14.6M +$2.66M +15.4% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022
2019 -$17.3M -$5.83M -51% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 -$11.4M -$3.79M -49.5% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020
2017 -$7.65M +$319K +4.01% 01 Jan 2017 31 Dec 2017 10-K 28 Mar 2019
2016 -$7.97M +$4.79M +37.5% 01 Jan 2016 31 Dec 2016 10-K 08 Mar 2018
2015 -$12.8M -$588K -4.83% 01 Jan 2015 31 Dec 2015 10-K/A 21 Mar 2017
2014 -$12.2M -$1.39M -12.9% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 -$10.8M -$5.72M -113% 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2015
2012 -$5.07M -$1.64M -47.8% 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2014
2011 -$3.43M 01 Jan 2011 31 Dec 2011 10-K 28 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.